Ulixertinib (BVD-523) and Hydroxychloroquine in Patients W Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas
Clinical trial NCT04145297 · COMPLETED
Trial details
- NCT number
- NCT04145297
- Sponsor
- University of Utah
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-17
- Primary completion
- 2022-06-10
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.